It is not usual for one life to be transformed into a living laboratory for the science of aging. When Maria Branyas Morera passed away at 117 years and 168 days, she bequeathed more than a record-breaking life she bequeathed biological clues. Dr. Manel Esteller, chairman of Genetics at the School of Medicine at the University of Barcelona, spent three years conducting a thorough study of her genetic composition, diet, and microbiome and discovering an unusual interaction between inherited resistance and lifestyle.
Genomically, Branyas had what Esteller termed “very good genes that defend against numerous disorders, numerous genetic variations no one has ever seen before.” Whole-genome sequencing identified protective alleles not present in larger population data sets, which is also in line with large-scale exome research demonstrating that rare protein-truncating variants (PTVs) in specific disease-associated genes can have a profoundly effect on lifespan. In UK Biobank studies, loss-of-function mutations in the genes BRCA2, BRCA1, and TET2 predicted decreased survival, highlighting the way in which her lack of such high-risk variants helped to protect her from cancer, cardiovascular disease, and neurodegeneration deep into advanced old age.
Her lifestyle supported these genetic benefits. She eschewed smoking and booze, preferred fish and olive oil, and, most significantly, ate three portions of plain, unsweetened yogurt each day. This routine, Esteller wrote, stocked her gut with good bacteria, specifically members of the genus Bifidobacterium, which have been shown to fight chronic inflammation a key force behind aging. Chronic low-grade inflammation, or “inflammaging,” is a defining feature of aging, usually associated with dysbiosis in the gut microbiota. Probiotics, such as Bifidobacterium and Lactobacillus species, have been shown to improve gut barrier function, regulate immune responses, and expand microbial richness, all of which are protective against systemic inflammation.
Microbiome sequencing of Branyas’ stool specimens demonstrated dominance by Bifidobacterium-related taxa. The study could not definitively confirm this was due to her yogurt consumption without longitudinal sampling, but such is supported by findings from large cohorts. In the TwinsUK study, cohort, yogurt consumers had increased Streptococcus thermophilus and Bifidobacterium animalis subsp. lactis starter species in fermented milk products along with decreased visceral fat mass and better metabolic phenotypes. These microorganisms are able to survive transit through the gastrointestinal tract, transiently become part of the gut community, and yield metabolites like 3-hydroxyoctanoic acid, an agonist of hydroxycarboxylic acid receptor 3 (HCA3) that acts to blunt inflammation.
Molecularly, the case of Branyas presents the difference between being very old and ill. Her phenotype was one where very advanced age and poor health are not inherently correlated, according to Cell Reports Medicine, “extremely advanced age and poor health are not intrinsically linked,” and dementia confirms. This segregation is apparent at the cellular level: her tissues contained none of the patterns of molecular damage seen in the elderly with chronic disease, indicating that both her genome and microbiome played a role in sustaining physiological integrity.
The technical consistency of the study was impressive. Investigators drew samples from blood, saliva, urine, and stool at multiple time points, using high-throughput sequencing to capture microbial taxa and metabolic pathways. They discovered that her intestinal ecosystem had a balance that was weighted in favor of anti-inflammatory species, similar to profiles observed in other long-lived groups in which genera like Akkermansia, Christensenellaceae, and Ruminococcaceae are still prevalent even with age-related changes. This conservation of protective taxa might prove to be essential; in aging groups, reduced microbial diversity and increased pro-inflammatory species are associated with greater intestinal permeability, systemic inflammation, and frailty.
Branyas’ love for yogurt she once posted online that it “gives life” aligns with over a century of scientific curiosity about fermented dairy. Elie Metchnikoff, in the early 1900s, hypothesized that lactic acid bacteria in yogurt could prolong life by suppressing harmful gut microbes. Modern metagenomic and metabolomic studies now provide mechanistic backing: yogurt-derived microbes can transiently alter gut composition, influence host metabolism, and interact with immune signaling in ways that may cumulatively support longevity.
Her tale, based on genetic singularity and everyday food microbiome modulation, provides a real-life illustration of how genomics and nutritional microbiology converge to guide strategies for healthy aging. For clinicians and researchers interested in longevity, it serves to highlight the promise of incorporating genomic screening into dietary approaches aimed at curbing inflammation, maintaining organ integrity, and maximizing healthspan.
